JAMES KIM: Open Payments
NPI 1316041726 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,515 in 84 payments from 12 companies in 2025. Trend: 2023 $842 · 2024 $1,809 · 2025 $1,515
Food & beverage: $1,515
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $402 |
| Medtronic, Inc. | 18 | $400 |
| Collegium Pharmaceutical, Inc. | 16 | $201 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $102 |
| Electronic Waveform Lab, Inc. | 10 | $93 |
| MML US, Inc. | 3 | $92 |
| PFIZER INC. | 3 | $66 |
| HEARTFLOW, INC. | 1 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| Globus Medical, Inc. | 1 | $26 |
Products named: INTELLIS ADAPTIVESTIM, QULIPTA, Belbuca, UBRELVY, JOURNAVX, ReActiv8, INCEPTIV, NURTEC ODT.
Industry payments across CA — which companies pay providers there.
